Monografie
Efficacy and safety of ticagrelor versus prasugrel in women and men with acute coronary syndrome: A pre-specified, sex-specific analysis of the ISAR-REACT 5 trial
- Sprache
-
Englisch
- Identifier
-
1260974154
Beteiligte Personen und Organisationen
Gewalt, Senta Maria
Lahu, Shqipdona
Ndrepepa, Gjin
Pellegrini, Costanza
Bernlochner, Isabell
Neumann, Franz-Josef
Menichelli, Maurizio
Morath, Tanja
Witzenbichler, Bernhard
Wöhrle, Jochen
Hoppe, Katharina
Richardt, Gert
Laugwitz, Karl-Ludwig
Schunkert, Heribert
Kastrati, Adnan
Schüpke, Stefanie
Mayer, Katharina
Lahu, Shqipdona
Ndrepepa, Gjin
Pellegrini, Costanza
Bernlochner, Isabell
Neumann, Franz-Josef
Menichelli, Maurizio
Morath, Tanja
Witzenbichler, Bernhard
Wöhrle, Jochen
Hoppe, Katharina
Richardt, Gert
Laugwitz, Karl-Ludwig
Schunkert, Heribert
Kastrati, Adnan
Schüpke, Stefanie
Mayer, Katharina
- DOI
-
10.5551/jat.62776
- URN
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
05.07.2022, 13:19 MESZ
Objekttyp
- Monografie
Beteiligte
- Gewalt, Senta Maria
- Lahu, Shqipdona
- Ndrepepa, Gjin
- Pellegrini, Costanza
- Bernlochner, Isabell
- Neumann, Franz-Josef
- Menichelli, Maurizio
- Morath, Tanja
- Witzenbichler, Bernhard
- Wöhrle, Jochen
- Hoppe, Katharina
- Richardt, Gert
- Laugwitz, Karl-Ludwig
- Schunkert, Heribert
- Kastrati, Adnan
- Schüpke, Stefanie
- Mayer, Katharina
Ähnliche Objekte (12)
Assessment of impact of patient recruitment volume on risk profile, outcomes, and treatment effect in a randomized trial of ticagrelor versus prasugrel in acute coronary syndromes
Ticagrelor or Prasugrel in patients with acute coronary syndromes and Diabetes Mellitus
Prior myocardial infarction and treatment effect of ticagrelor versus prasugrel in patients with acute coronary syndromes ‐ a post‐hoc analysis of the ISAR‐REACT 5 trial
Association between platelet count and treatment effect of ticagrelor or prasugrel in patients with acute coronary syndromes
Rotational atherectomy of calcified coronary lesions: current practice and insights from two randomized trials
Six versus twelve months clopidogrel therapy after drug-eluting stenting in patients with acute coronary syndrome: an ISAR-SAFE study subgroup analysis
Coronary artery disease and myocardial revascularisation failure: diagnosis, mechanisms, prevention and management
Design and rationale of the COMPARE-ACUTE trial: fractional flow reserve-guided primary multivessel percutaneous coronary intervention to improve guideline indexed actual standard of care for treatment of ST-elevation myocardial infarction in patients with multivessel coronary disease
A Meta-Analysis of 20 Randomized Trials of a PCI-Based Strategy in Patients With Stable Coronary Artery Disease
Use of intravascular optical coherence tomography for evaluation of vessel healing following coronary stent implantation and elucidation of mechanisms of stent failure (with a particular focus on neoatherosclerosis)
Human iPSC-derived cardiomyocytes as platforms for cardiac disease modeling, therapeutic discovery and safety pharmacology
Ticagrelor or prasugrel in patients with acute coronary syndrome with off-hour versus on-hour presentation: a subgroup analysis of the ISAR-REACT 5 trial
Assessment of impact of patient recruitment volume on risk profile, outcomes, and treatment effect in a randomized trial of ticagrelor versus prasugrel in acute coronary syndromes
Ticagrelor or Prasugrel in patients with acute coronary syndromes and Diabetes Mellitus
Prior myocardial infarction and treatment effect of ticagrelor versus prasugrel in patients with acute coronary syndromes ‐ a post‐hoc analysis of the ISAR‐REACT 5 trial
Association between platelet count and treatment effect of ticagrelor or prasugrel in patients with acute coronary syndromes
Rotational atherectomy of calcified coronary lesions: current practice and insights from two randomized trials
Six versus twelve months clopidogrel therapy after drug-eluting stenting in patients with acute coronary syndrome: an ISAR-SAFE study subgroup analysis
Coronary artery disease and myocardial revascularisation failure: diagnosis, mechanisms, prevention and management
Design and rationale of the COMPARE-ACUTE trial: fractional flow reserve-guided primary multivessel percutaneous coronary intervention to improve guideline indexed actual standard of care for treatment of ST-elevation myocardial infarction in patients with multivessel coronary disease
A Meta-Analysis of 20 Randomized Trials of a PCI-Based Strategy in Patients With Stable Coronary Artery Disease
Use of intravascular optical coherence tomography for evaluation of vessel healing following coronary stent implantation and elucidation of mechanisms of stent failure (with a particular focus on neoatherosclerosis)
Human iPSC-derived cardiomyocytes as platforms for cardiac disease modeling, therapeutic discovery and safety pharmacology
Ticagrelor or prasugrel in patients with acute coronary syndrome with off-hour versus on-hour presentation: a subgroup analysis of the ISAR-REACT 5 trial
Assessment of impact of patient recruitment volume on risk profile, outcomes, and treatment effect in a randomized trial of ticagrelor versus prasugrel in acute coronary syndromes
Ticagrelor or Prasugrel in patients with acute coronary syndromes and Diabetes Mellitus
Prior myocardial infarction and treatment effect of ticagrelor versus prasugrel in patients with acute coronary syndromes ‐ a post‐hoc analysis of the ISAR‐REACT 5 trial
Association between platelet count and treatment effect of ticagrelor or prasugrel in patients with acute coronary syndromes
Rotational atherectomy of calcified coronary lesions: current practice and insights from two randomized trials
Six versus twelve months clopidogrel therapy after drug-eluting stenting in patients with acute coronary syndrome: an ISAR-SAFE study subgroup analysis
Coronary artery disease and myocardial revascularisation failure: diagnosis, mechanisms, prevention and management
Design and rationale of the COMPARE-ACUTE trial: fractional flow reserve-guided primary multivessel percutaneous coronary intervention to improve guideline indexed actual standard of care for treatment of ST-elevation myocardial infarction in patients with multivessel coronary disease
A Meta-Analysis of 20 Randomized Trials of a PCI-Based Strategy in Patients With Stable Coronary Artery Disease
Use of intravascular optical coherence tomography for evaluation of vessel healing following coronary stent implantation and elucidation of mechanisms of stent failure (with a particular focus on neoatherosclerosis)
Human iPSC-derived cardiomyocytes as platforms for cardiac disease modeling, therapeutic discovery and safety pharmacology